177 related articles for article (PubMed ID: 31431386)
1. Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of reference.
Zamboglou C; Fassbender TF; Steffan L; Schiller F; Fechter T; Carles M; Kiefer S; Rischke HC; Reichel K; Schmidt-Hegemann NS; Ilhan H; Chirindel AF; Nicolas G; Henkenberens C; Derlin T; Bronsert P; Mavroidis P; Chen RC; Meyer PT; Ruf J; Grosu AL
Radiother Oncol; 2019 Dec; 141():208-213. PubMed ID: 31431386
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Manual and Semi-Automatic [
Spohn SKB; Kramer M; Kiefer S; Bronsert P; Sigle A; Schultze-Seemann W; Jilg CA; Sprave T; Ceci L; Fassbender TF; Nicolay NH; Ruf J; Grosu AL; Zamboglou C
Front Oncol; 2020; 10():600690. PubMed ID: 33365271
[TBL] [Abstract][Full Text] [Related]
3. Comparison of
Zamboglou C; Drendel V; Jilg CA; Rischke HC; Beck TI; Schultze-Seemann W; Krauss T; Mix M; Schiller F; Wetterauer U; Werner M; Langer M; Bock M; Meyer PT; Grosu AL
Theranostics; 2017; 7(1):228-237. PubMed ID: 28042330
[TBL] [Abstract][Full Text] [Related]
4. [
Bettermann AS; Zamboglou C; Kiefer S; Jilg CA; Spohn S; Kranz-Rudolph J; Fassbender TF; Bronsert P; Nicolay NH; Gratzke C; Bock M; Ruf J; Benndorf M; Grosu AL
Radiother Oncol; 2019 Dec; 141():214-219. PubMed ID: 31431366
[TBL] [Abstract][Full Text] [Related]
5. Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference.
Zamboglou C; Carles M; Fechter T; Kiefer S; Reichel K; Fassbender TF; Bronsert P; Koeber G; Schilling O; Ruf J; Werner M; Jilg CA; Baltas D; Mix M; Grosu AL
Theranostics; 2019; 9(9):2595-2605. PubMed ID: 31131055
[No Abstract] [Full Text] [Related]
6. Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network.
Kostyszyn D; Fechter T; Bartl N; Grosu AL; Gratzke C; Sigle A; Mix M; Ruf J; Fassbender TF; Kiefer S; Bettermann AS; Nicolay NH; Spohn S; Kramer MU; Bronsert P; Guo H; Qiu X; Wang F; Henkenberens C; Werner RA; Baltas D; Meyer PT; Derlin T; Chen M; Zamboglou C
J Nucl Med; 2021 Jun; 62(6):823-828. PubMed ID: 33127624
[TBL] [Abstract][Full Text] [Related]
7.
Draulans C; Pos F; Smeenk RJ; Kerkmeijer L; Vogel WV; Nagarajah J; Janssen M; Mai C; Heijmink S; van der Leest M; Zámecnik P; Oyen R; Isebaert S; Maes F; Joniau S; Kunze-Busch M; De Roover R; Defraene G; van der Heide UA; Goffin K; Haustermans K
Pract Radiat Oncol; 2021; 11(3):202-211. PubMed ID: 33941347
[TBL] [Abstract][Full Text] [Related]
8. Optimal
Draulans C; De Roover R; van der Heide UA; Kerkmeijer L; Smeenk RJ; Pos F; Vogel WV; Nagarajah J; Janssen M; Isebaert S; Maes F; Mai C; Oyen R; Joniau S; Kunze-Busch M; Goffin K; Haustermans K
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1211-1218. PubMed ID: 33025093
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. (68)Ga-HBED-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: A Voxel-Wise Comparison.
Zamboglou C; Schiller F; Fechter T; Wieser G; Jilg CA; Chirindel A; Salman N; Drendel V; Werner M; Mix M; Meyer PT; Grosu AL
Theranostics; 2016; 6(10):1619-28. PubMed ID: 27446496
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
van Leeuwen PJ; Emmett L; Ho B; Delprado W; Ting F; Nguyen Q; Stricker PD
BJU Int; 2017 Feb; 119(2):209-215. PubMed ID: 27207581
[TBL] [Abstract][Full Text] [Related]
12. MRI versus ⁶⁸Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer.
Zamboglou C; Wieser G; Hennies S; Rempel I; Kirste S; Soschynski M; Rischke HC; Fechter T; Jilg CA; Langer M; Meyer PT; Bock M; Grosu AL
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):889-897. PubMed ID: 26592938
[TBL] [Abstract][Full Text] [Related]
13. Gross tumor volume delineation in primary prostate cancer on
Zhang YN; Lu ZG; Wang SD; Lu X; Zhu LL; Yang X; Fu LP; Zhao J; Wang HF; Xiang ZL
Cancer Imaging; 2022 Jul; 22(1):36. PubMed ID: 35869521
[TBL] [Abstract][Full Text] [Related]
14. Deep learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer.
Holzschuh JC; Mix M; Ruf J; Hölscher T; Kotzerke J; Vrachimis A; Doolan P; Ilhan H; Marinescu IM; Spohn SKB; Fechter T; Kuhn D; Bronsert P; Gratzke C; Grosu R; Kamran SC; Heidari P; Ng TSC; Könik A; Grosu AL; Zamboglou C
Radiother Oncol; 2023 Nov; 188():109774. PubMed ID: 37394103
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Multiple Segmentation Methods for Volumetric Delineation of Primary Prostate Cancer with Prostate-Specific Membrane Antigen-Targeted
Wang F; Liu C; Vidal I; Mana-Ay M; Voter AF; Solnes LB; Ross AE; Gafita A; Schaeffer EM; Bivalacqua TJ; Pienta KJ; Pomper MG; Lodge MA; Song DY; Oldan JD; Allaf ME; De Marzo AM; Sheikhbahaei S; Gorin MA; Rowe SP
J Nucl Med; 2024 Jan; 65(1):87-93. PubMed ID: 38050147
[TBL] [Abstract][Full Text] [Related]
16. Intraindividual comparison between
Spohn S; Jaegle C; Fassbender TF; Sprave T; Gkika E; Nicolay NH; Bock M; Ruf J; Benndorf M; Gratzke C; Grosu AL; Zamboglou C
Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2796-2803. PubMed ID: 32342192
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using
Zamboglou C; Sachpazidis I; Koubar K; Drendel V; Wiehle R; Kirste S; Mix M; Schiller F; Mavroidis P; Meyer PT; Werner M; Grosu AL; Baltas D
Radiother Oncol; 2017 Jun; 123(3):472-477. PubMed ID: 28499607
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Accuracy of
Cantiello F; Gangemi V; Cascini GL; Calabria F; Moschini M; Ferro M; Musi G; Butticè S; Salonia A; Briganti A; Damiano R
Urology; 2017 Aug; 106():139-145. PubMed ID: 28438628
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer GTV delineation with biparametric MRI and
Hearn N; Blazak J; Vivian P; Vignarajah D; Cahill K; Atwell D; Lagopoulos J; Min M
Br J Radiol; 2021 Mar; 94(1119):20201174. PubMed ID: 33507812
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic performance of 68GA-PSMA PET/CTin patients with prostate cancer].
Veliev EI; Tomilov AA; Goncharuk DA; Bogdanov AB; Golubtsova EN
Urologiia; 2018 Jul; (3):105-110. PubMed ID: 30035428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
